Skip to main content

Table 1 Patient characteristics, volume of CTVs and details on imaging for verification

From: Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes

Patient

Primary tumor site

Gender

Clinical/pathological TNM-stage

No. of cCTs

CTV / cm3

Low-risk

High-risk

1

Mucoepidermoid carcinoma of left parotid gland

F

pT1 N0 M0

6

159.7

(150.5–158.7)

17.1

(15.5–17.8)

2

Adenoidcystic carcinoma of right parotid gland

M

pT1 N0 M0

13

92.3

(87.7–96.3)

44.5

(42.3–46.4)

3

Small salivary glands of oral cavity

M

pT1 N2b M0

5

218.2

(199.9–211.2)

55.9

(50.3–53.3)

4

Lateral border of tongue

F

pT1 N2b M0

11

79.8

(79.0–83.9)

16.0

(16.2–17.1)

5

Right tonsil

M

pT2 N2b M0

11

150.2

(136.2–157.0)

43.2

(39.2–45.5)

6

Maxillary sinus

M

rcT2 N1 M0

5

134.9

(130.3–141.5)

28.8

(24.2–27.7)

7

Adenoidcystic carcinoma of left parotid gland

M

pT4a N0 M0

3

246.0

(238.4–242.6)

93.7

(87.9–91.7)

8

Recurrent adenoidcystic carcinoma of right submandibular gland

M

rpT2 N0 M0

6

78.7

(78.1–81.9)

22.5

(23.1–24.0)

  1. Abbreviations: F Female, M Male, cCT Control CTs, CTV Clinical target volume
  2. CTV values: pCT (range in cCTs)